Nexium (Esomeprazole)

Esomeprazole selectively and irreversibly inhibits the gastric H+/K+ ATPase (proton pump) on parietal cells, which is the final step in acid secretion. This inhibition reduces both basal and stimulated gastric acid output, raising gastric pH and allowing healing of acid‑damaged tissues.

The appropriate dose of Nexium is determined by the prescribing healthcare professional based on the specific indication, patient characteristics, and clinical response. Dosage regimens may vary, and the prescriber will provide individualized instructions.

Safety data for esomeprazole in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Nexium to pregnant or nursing individuals. The decision is made on a case‑by‑case basis.

To request Nexium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nexium (esomeprazole) belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, esomeprazole provides a consistent pharmacokinetic profile and is often selected for its efficacy in severe acid‑related conditions.

Nexium should be stored at temperatures below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Nexium is taken orally, usually as a tablet or capsule, with or without food according to the prescriber’s instructions. Swallow the dosage form whole with a glass of water and follow any specific timing guidance provided by the healthcare professional.

Serious risks, though uncommon, include Clostridioides difficile‑associated diarrhea, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, liver enzyme elevations, low magnesium levels with prolonged use, and an increased risk of bone fractures with long‑term therapy.

Patients with known hypersensitivity to esomeprazole, other proton pump inhibitors, or any component of the formulation should avoid Nexium. Caution is also advised for individuals with severe liver disease, and it should not be used in conjunction with medications that have major contraindicated interactions without medical supervision.